Takefumi Satoh
National Sagamihara Hospital, Okayama Psychiatric Medical Center
Papers
2
Total Citations
32
H-Index
2
About
Takefumi Satoh is a leading urological oncologist whose research centers on preserving and understanding quality of life in men treated for localized prostate cancer. His most impactful work, a 2011 study with 27 citations, was among the first to dissect the distinct factors predicting both early and late-phase declines in sexual health-related quality of life following radical prostatectomy. By clarifying that the trajectory of sexual recovery is not uniform, Satoh provided clinicians with critical insights for patient counseling and tailored rehabilitation strategies. He has further advanced the field through comprehensive reviews, such as his 2019 analysis of health-related quality of life outcomes after low dose‑rate brachytherapy. This work systematically compared brachytherapy against competing modalities like surgery and active surveillance, helping to define its role in a modern, patient-centered treatment algorithm. Through his focused investigation of patient-reported outcomes, Satoh has made a significant contribution to moving prostate cancer care beyond mere survival, championing the importance of long-term functional well-being and shared decision-making.
Research Focus
Key Achievements
Top Papers
- 1
- 2